<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-10-11" modified="2020-10-07" version="174">
<accession>Q8N726</accession>
<accession>D3DRK2</accession>
<accession>Q13195</accession>
<accession>Q13399</accession>
<accession>Q16360</accession>
<accession>Q7KZR9</accession>
<name>ARF_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="25">Tumor suppressor ARF</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="24">Alternative reading frame</fullName>
<shortName evidence="24">ARF</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="31">Cyclin-dependent kinase inhibitor 2A</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="24">p14ARF</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="29 31">CDKN2A</name>
<name type="synonym" evidence="28">CDKN2</name>
<name type="synonym">MLM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="28">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="2988" last="2994">
<title>Complex structure and regulation of the P16 (MTS1) locus.</title>
<authorList>
<person name="Stone S."/>
<person name="Jiang P."/>
<person name="Dayananth P."/>
<person name="Tavtigian S.V."/>
<person name="Katcher H."/>
<person name="Parry D."/>
<person name="Peters G."/>
<person name="Kamb A."/>
</authorList>
<dbReference type="PubMed" id="7606716"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2" evidence="25 27">
<citation type="submission" date="1995-10" db="EMBL/GenBank/DDBJ databases">
<title>mRNA isoform with alternate first exon-encoded sequences at the cyclin-dependent kinase inhibitor 2 (p16INK4/MTS1) locus and mapping analysis of the region by using long-PCR.</title>
<authorList>
<person name="Linnenbach A.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3" evidence="25 27">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT SER-17</scope>
</reference>
<reference key="4" evidence="30">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5" evidence="25 27">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7" evidence="25 26">
<citation type="journal article" date="1995" name="Oncogene" volume="11" first="21" last="29">
<title>A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.</title>
<authorList>
<person name="Duro D."/>
<person name="Bernard O."/>
<person name="Della Valle V."/>
<person name="Berger R."/>
<person name="Larsen C.J."/>
</authorList>
<dbReference type="PubMed" id="7624129"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue evidence="26">Hematopoietic</tissue>
</source>
</reference>
<reference key="8" evidence="25 27">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="9" evidence="25">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="5001" last="5014">
<title>The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.</title>
<authorList>
<person name="Stott F.J."/>
<person name="Bates S."/>
<person name="James M.C."/>
<person name="McConnell B.B."/>
<person name="Starborg M."/>
<person name="Brookes S."/>
<person name="Palmero I."/>
<person name="Ryan K."/>
<person name="Hara E."/>
<person name="Vousden K.H."/>
<person name="Peters G."/>
</authorList>
<dbReference type="PubMed" id="9724636"/>
<dbReference type="DOI" id="10.1093/emboj/17.17.5001"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MDM2</scope>
</reference>
<reference key="10" evidence="25">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="836" last="848">
<title>Human ARF protein interacts with topoisomerase I and stimulates its activity.</title>
<authorList>
<person name="Karayan L."/>
<person name="Riou J.-F."/>
<person name="Seite P."/>
<person name="Migeon J."/>
<person name="Cantereau A."/>
<person name="Larsen C.-J."/>
</authorList>
<dbReference type="PubMed" id="11314011"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204170"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TOP1</scope>
</reference>
<reference key="11" evidence="25">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="1033" last="1041">
<title>Human ARF binds E2F1 and inhibits its transcriptional activity.</title>
<authorList>
<person name="Eymin B."/>
<person name="Karayan L."/>
<person name="Seite P."/>
<person name="Brambilla C."/>
<person name="Brambilla E."/>
<person name="Larsen C.-J."/>
<person name="Gazzeri S."/>
</authorList>
<dbReference type="PubMed" id="11314038"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204220"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH E2F1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37765" last="37770">
<title>CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.</title>
<authorList>
<person name="Hasan M.K."/>
<person name="Yaguchi T."/>
<person name="Sugihara T."/>
<person name="Kumar P.K.R."/>
<person name="Taira K."/>
<person name="Reddel R.R."/>
<person name="Kaul S.C."/>
<person name="Wadhwa R."/>
</authorList>
<dbReference type="PubMed" id="12154087"/>
<dbReference type="DOI" id="10.1074/jbc.m204177200"/>
</citation>
<scope>INTERACTION WITH CDKN2AIP</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Exp. Gerontol." volume="38" first="245" last="252">
<title>A novel putative collaborator of p19ARF.</title>
<authorList>
<person name="Wadhwa R."/>
<person name="Sugihara T."/>
<person name="Hasan M.K."/>
<person name="Duncan E.L."/>
<person name="Taira K."/>
<person name="Kaul S.C."/>
</authorList>
<dbReference type="PubMed" id="12581788"/>
<dbReference type="DOI" id="10.1016/s0531-5565(02)00180-8"/>
</citation>
<scope>INTERACTION WITH CDKN2AIP</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4981" last="4989">
<title>Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition.</title>
<authorList>
<person name="Rizos H."/>
<person name="Diefenbach E."/>
<person name="Badhwar P."/>
<person name="Woodruff S."/>
<person name="Becker T.M."/>
<person name="Rooney R.J."/>
<person name="Kefford R.F."/>
</authorList>
<dbReference type="PubMed" id="12446718"/>
<dbReference type="DOI" id="10.1074/jbc.m210978200"/>
</citation>
<scope>INTERACTION WITH E4F1</scope>
</reference>
<reference key="15" evidence="25">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="1151" last="1164">
<title>Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.</title>
<authorList>
<person name="Itahana K."/>
<person name="Bhat K.P."/>
<person name="Jin A."/>
<person name="Itahana Y."/>
<person name="Hawke D."/>
<person name="Kobayashi R."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="14636574"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00431-3"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NPM1</scope>
</reference>
<reference key="16" evidence="25">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="1822" last="1835">
<title>p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice.</title>
<authorList>
<person name="Eymin B."/>
<person name="Leduc C."/>
<person name="Coll J.-L."/>
<person name="Brambilla E."/>
<person name="Gazzeri S."/>
</authorList>
<dbReference type="PubMed" id="12660818"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206303"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17" evidence="25">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="8097" last="8104">
<title>Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.</title>
<authorList>
<person name="Ayrault O."/>
<person name="Andrique L."/>
<person name="Larsen C.-J."/>
<person name="Seite P."/>
</authorList>
<dbReference type="PubMed" id="15361825"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207968"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TOP1</scope>
</reference>
<reference key="18" evidence="25">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="326" first="242" last="248">
<title>The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Kurita M."/>
<person name="Mizumoto K."/>
<person name="Moriyama M."/>
<person name="Aiso S."/>
<person name="Nishimoto I."/>
<person name="Matsuoka M."/>
</authorList>
<dbReference type="PubMed" id="15567177"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.11.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BCL6</scope>
</reference>
<reference key="19" evidence="25">
<citation type="journal article" date="2005" name="Cell" volume="121" first="1071" last="1083">
<title>ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.</title>
<authorList>
<person name="Chen D."/>
<person name="Kon N."/>
<person name="Li M."/>
<person name="Zhang W."/>
<person name="Qin J."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="15989956"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.03.037"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HUWE1</scope>
</reference>
<reference key="20" evidence="25">
<citation type="journal article" date="2005" name="Cell Cycle" volume="4" first="597" last="603">
<title>p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners.</title>
<authorList>
<person name="Rizos H."/>
<person name="Woodruff S."/>
<person name="Kefford R.F."/>
</authorList>
<dbReference type="PubMed" id="15876874"/>
<dbReference type="DOI" id="10.4161/cc.4.4.1597"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH UBE2I</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Biochem. J." volume="393" first="489" last="501">
<title>A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.</title>
<authorList>
<person name="Wang J."/>
<person name="He X."/>
<person name="Luo Y."/>
<person name="Yarbrough W.G."/>
</authorList>
<dbReference type="PubMed" id="16173922"/>
<dbReference type="DOI" id="10.1042/bj20050960"/>
</citation>
<scope>INTERACTION WITH CDK5RAP3 AND MDM2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>REGION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="463" last="475">
<title>A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death.</title>
<authorList>
<person name="Reef S."/>
<person name="Zalckvar E."/>
<person name="Shifman O."/>
<person name="Bialik S."/>
<person name="Sabanay H."/>
<person name="Oren M."/>
<person name="Kimchi A."/>
</authorList>
<dbReference type="PubMed" id="16713577"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.04.014"/>
</citation>
<scope>FUNCTION (ISOFORM SMARF)</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM SMARF)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM SMARF)</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="1322" last="1333">
<title>A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.</title>
<authorList>
<person name="Tompkins V.S."/>
<person name="Hagen J."/>
<person name="Frazier A.A."/>
<person name="Lushnikova T."/>
<person name="Fitzgerald M.P."/>
<person name="di Tommaso A.D."/>
<person name="Ladeveze V."/>
<person name="Domann F.E."/>
<person name="Eischen C.M."/>
<person name="Quelle D.E."/>
</authorList>
<dbReference type="PubMed" id="17110379"/>
<dbReference type="DOI" id="10.1074/jbc.m609612200"/>
</citation>
<scope>INTERACTION WITH TBRG1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="6677" last="6683">
<title>The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein.</title>
<authorList>
<person name="Reef S."/>
<person name="Shifman O."/>
<person name="Oren M."/>
<person name="Kimchi A."/>
</authorList>
<dbReference type="PubMed" id="17486078"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210485"/>
</citation>
<scope>INTERACTION WITH C1QBP</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="11453" last="11460">
<title>Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1.</title>
<authorList>
<person name="Huang Y."/>
<person name="Wu M."/>
<person name="Li H.Y."/>
</authorList>
<dbReference type="PubMed" id="18305112"/>
<dbReference type="DOI" id="10.1074/jbc.m708544200"/>
</citation>
<scope>INTERACTION WITH COMMD1</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Nature" volume="464" first="624" last="627">
<title>Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.</title>
<authorList>
<person name="Chen D."/>
<person name="Shan J."/>
<person name="Zhu W.G."/>
<person name="Qin J."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="20208519"/>
<dbReference type="DOI" id="10.1038/nature08820"/>
</citation>
<scope>UBIQUITINATION BY TRIP12</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Exp. Cell Res." volume="318" first="187" last="195">
<title>A novel proapoptotic gene PANO encodes a post-translational modulator of the tumor suppressor p14ARF.</title>
<authorList>
<person name="Watari A."/>
<person name="Li Y."/>
<person name="Higashiyama S."/>
<person name="Yutsudo M."/>
</authorList>
<dbReference type="PubMed" id="22094112"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2011.10.019"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Oncotarget" volume="8" first="16293" last="16302">
<title>GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.</title>
<authorList>
<person name="Lee S."/>
<person name="Cho Y.E."/>
<person name="Kim S.H."/>
<person name="Kim Y.J."/>
<person name="Park J.H."/>
</authorList>
<dbReference type="PubMed" id="27323397"/>
<dbReference type="DOI" id="10.18632/oncotarget.9957"/>
</citation>
<scope>INTERACTION WITH NOP53</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<comment type="function">
<text evidence="2 3 7 8 9 10 11 12 14 17 19 21">Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with COMMD1 and promotes its 'Lys63'-linked polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Isoform smARF may be involved in regulation of autophagy and caspase-independent cell death; the short-lived mitochondrial isoform is stabilized by C1QBP.</text>
</comment>
<comment type="subunit">
<text evidence="2 3 4 5 6 8 9 10 11 12 13 15 16 17 20 21">Does not interact with cyclins, CDK1, CDK2, CDK4, CDK5 or CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and UBE2I/UBC9. Interacts with TBRG1 and COMMD1. Interacts with CDKN2AIP and E4F1. Interacts with CDK5RAP3 and MDM2; form a ternary complex involved in regulation of p53/TP53 (PubMed:16173922). Isoform smARF interacts with C1QBP. Interacts with NOP53; the interaction is direct and promotes ARF nucleoplasmic relocalization and ubiquitin-mediated proteasomal degradation (PubMed:27323397).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-347528">
<id>Q07021</id>
<label>C1QBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-2834611">
<id>P18146</id>
<label>EGR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-625934">
<id>Q7Z6Z7</id>
<label>HUWE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-714236">
<id>Q13330</id>
<label>MTA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-878369">
<id>P04198</id>
<label>MYCN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-308443">
<id>Q14669</id>
<label>TRIP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-3923307">
<id>Q8TAQ5</id>
<label>ZNF420</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-625922">
<id>Q8N726</id>
</interactant>
<interactant intactId="EBI-1185167">
<id>Q8AZK7</id>
<label>EBNA-LP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 17 19 20">Nucleus</location>
<location evidence="13 17 19 20">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17 20">Nucleus</location>
<location evidence="17 20">Nucleoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform smARF</molecule>
<subcellularLocation>
<location evidence="14">Mitochondrion</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8N726-1</id>
<name evidence="23">tumor suppressor ARF</name>
<name evidence="24">p14ARF</name>
<name>p19ARF</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P42771-1</id>
<name evidence="25">1</name>
<name evidence="25">p16INK4a</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42771-2</id>
<name evidence="25">2</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42771-3</id>
<name evidence="25">3</name>
<name evidence="25">p12</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42771-4</id>
<name>5</name>
<name>p16gamma</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>Q8N726-2</id>
<name>smARF</name>
<sequence type="described" ref="VSP_044962"/>
</isoform>
<text evidence="1">Isoform 1 and isoform tumor suppressor ARF arise due to the use of two alternative first exons joined to a common exon 2 at the same acceptor site but in different reading frames, resulting in two completely different isoforms.</text>
</comment>
<comment type="PTM">
<text evidence="18 20">Ubiquitinated in normal cells by TRIP12 via the ubiquitin fusion degradation (UFD) pathway, a process that mediates ubiquitination at the N-terminus, regardless of the absence of lysine residues. Ubiquitination leads to its proteasomal degradation. In cancer cells, however, TRIP12 is located in a different cell compartment, preventing ubiquitination and degradation.</text>
</comment>
<comment type="caution">
<text evidence="25">The proteins described here are encoded by the gene CDKN2A, but are completely unrelated in terms of sequence and function to cyclin-dependent kinase inhibitor 2A (AC P42771) which is encoded by the same gene.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAB01737" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC60649" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH15960" version="3"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH21998" version="3"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAM77919" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAH70601" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="EAW58600" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="EAW58601" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdkn2a/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CDKN2aID146.html"/>
</comment>
<dbReference type="EMBL" id="S78535">
<property type="protein sequence ID" value="AAC60649.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U38945">
<property type="protein sequence ID" value="AAB01737.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF527803">
<property type="protein sequence ID" value="AAM77919.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL449423">
<property type="protein sequence ID" value="CAH70601.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58600.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58601.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015960">
<property type="protein sequence ID" value="AAH15960.3"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021998">
<property type="protein sequence ID" value="AAH21998.3"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U26727">
<property type="protein sequence ID" value="AAA82236.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007020">
<property type="protein sequence ID" value="AAP35666.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6511.2">
<molecule id="Q8N726-1"/>
</dbReference>
<dbReference type="PIR" id="I39004">
<property type="entry name" value="I39004"/>
</dbReference>
<dbReference type="RefSeq" id="NP_478102.2">
<molecule id="Q8N726-1"/>
<property type="nucleotide sequence ID" value="NM_058195.3"/>
</dbReference>
<dbReference type="SMR" id="Q8N726"/>
<dbReference type="BioGRID" id="107463">
<property type="interactions" value="236"/>
</dbReference>
<dbReference type="CORUM" id="Q8N726"/>
<dbReference type="DIP" id="DIP-24171N"/>
<dbReference type="IntAct" id="Q8N726">
<property type="interactions" value="65"/>
</dbReference>
<dbReference type="MINT" id="Q8N726"/>
<dbReference type="iPTMnet" id="Q8N726"/>
<dbReference type="BioMuta" id="CDKN2A"/>
<dbReference type="DMDM" id="384872321"/>
<dbReference type="jPOST" id="Q8N726"/>
<dbReference type="MassIVE" id="Q8N726"/>
<dbReference type="MaxQB" id="Q8N726"/>
<dbReference type="PeptideAtlas" id="Q8N726"/>
<dbReference type="PRIDE" id="Q8N726"/>
<dbReference type="ProteomicsDB" id="72258">
<molecule id="Q8N726-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="3608">
<property type="antibodies" value="1402 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1029"/>
<dbReference type="Ensembl" id="ENST00000530628">
<molecule id="Q8N726-1"/>
<property type="protein sequence ID" value="ENSP00000432664"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000579755">
<molecule id="Q8N726-1"/>
<property type="protein sequence ID" value="ENSP00000462950"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="GeneID" id="1029"/>
<dbReference type="UCSC" id="uc003zpl.4">
<molecule id="Q8N726-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1029"/>
<dbReference type="DisGeNET" id="1029"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000147889.16"/>
<dbReference type="GeneCards" id="CDKN2A"/>
<dbReference type="HGNC" id="HGNC:1787">
<property type="gene designation" value="CDKN2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000147889">
<property type="expression patterns" value="Tissue enhanced (blood, pituitary gland)"/>
</dbReference>
<dbReference type="MalaCards" id="CDKN2A"/>
<dbReference type="MIM" id="600160">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8N726"/>
<dbReference type="OpenTargets" id="ENSG00000147889"/>
<dbReference type="PharmGKB" id="PA106"/>
<dbReference type="GeneTree" id="ENSGT00940000163078"/>
<dbReference type="HOGENOM" id="CLU_134503_0_0_1"/>
<dbReference type="OrthoDB" id="1435166at2759"/>
<dbReference type="PathwayCommons" id="Q8N726"/>
<dbReference type="Reactome" id="R-HSA-111471">
<property type="pathway name" value="Apoptotic factor-mediated response"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559585">
<property type="pathway name" value="Oncogene Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69541">
<property type="pathway name" value="Stabilization of p53"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941858">
<property type="pathway name" value="Regulation of RUNX3 expression and activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9645722">
<property type="pathway name" value="Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9646303">
<property type="pathway name" value="Evasion of Oncogene Induced Senescence Due to p14ARF Defects"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9646304">
<property type="pathway name" value="Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects"/>
</dbReference>
<dbReference type="SIGNOR" id="Q8N726"/>
<dbReference type="BioGRID-ORCS" id="1029">
<property type="hits" value="10 hits in 883 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CDKN2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="1029"/>
<dbReference type="Pharos" id="Q8N726">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000147889">
<property type="expression patterns" value="Expressed in adenohypophysis and 208 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8N726">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8N726">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0097371">
<property type="term" value="F:MDM2/MDM4 family protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019789">
<property type="term" value="F:SUMO transferase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990948">
<property type="term" value="F:ubiquitin ligase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0055105">
<property type="term" value="F:ubiquitin-protein transferase inhibitor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990000">
<property type="term" value="P:amyloid fibril formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008637">
<property type="term" value="P:apoptotic mitochondrial changes"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000422">
<property type="term" value="P:autophagy of mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051882">
<property type="term" value="P:mitochondrial depolarization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033088">
<property type="term" value="P:negative regulation of immature T cell proliferation in thymus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006469">
<property type="term" value="P:negative regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000435">
<property type="term" value="P:negative regulation of protein neddylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1903051">
<property type="term" value="P:negative regulation of proteolysis involved in cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904667">
<property type="term" value="P:negative regulation of ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:2000059">
<property type="term" value="P:negative regulation of ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051444">
<property type="term" value="P:negative regulation of ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043517">
<property type="term" value="P:positive regulation of DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1900182">
<property type="term" value="P:positive regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033235">
<property type="term" value="P:positive regulation of protein sumoylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901798">
<property type="term" value="P:positive regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070534">
<property type="term" value="P:protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902510">
<property type="term" value="P:regulation of apoptotic DNA fragmentation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010389">
<property type="term" value="P:regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046825">
<property type="term" value="P:regulation of protein export from nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903214">
<property type="term" value="P:regulation of protein targeting to mitochondrion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048103">
<property type="term" value="P:somatic stem cell division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="DisProt" id="DP02167">
<molecule id="Q8N726-1"/>
</dbReference>
<dbReference type="InterPro" id="IPR010868">
<property type="entry name" value="Tumor_suppres_ARF"/>
</dbReference>
<dbReference type="Pfam" id="PF07392">
<property type="entry name" value="P19Arf_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0698">rRNA processing</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Tumor suppressor ARF" id="PRO_0000144180">
<location>
<begin position="1"/>
<end position="132"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CDK5RAP3 and MDM2" evidence="13">
<location>
<begin position="1"/>
<end position="64"/>
</location>
</feature>
<feature type="splice variant" description="In isoform smARF." id="VSP_044962" evidence="25">
<location>
<begin position="1"/>
<end position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3731190." id="VAR_029287" evidence="22">
<original>P</original>
<variation>S</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987127." id="VAR_053033">
<original>G</original>
<variation>R</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34886500." id="VAR_053034">
<original>P</original>
<variation>L</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35741010." id="VAR_053035">
<original>G</original>
<variation>D</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAH15960/AAH21998 and 7; AAP35666." ref="6 7" evidence="25">
<original>PRL</original>
<variation>SWF</variation>
<location>
<begin position="28"/>
<end position="30"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB01737." ref="2" evidence="25">
<original>P</original>
<variation>L</variation>
<location>
<position position="94"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q64364"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11314011"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11314038"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12154087"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12446718"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12581788"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12660818"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14636574"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15361825"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15567177"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15876874"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15989956"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16173922"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16713577"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17110379"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17486078"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18305112"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20208519"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22094112"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27323397"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9724636"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11314011"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9724636"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<evidence key="26" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAA82236.1"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAB01737.1"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAC60649.1"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAM77919.1"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="CAH70601.1"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1787"/>
</source>
</evidence>
<sequence length="132" mass="13903" checksum="7739A9050C21BC96" modified="2012-04-18" version="2">MVRRFLVTLRIRRACGPPRVRVFVVHIPRLTGEWAAPGAPAAVALVLMLLRSQRLGQQPLPRRPGHDDGQRPSGGAAAAPRRGAQLRRPRHSHPTRARRCPGGLPGHAGGAAPGRGAAGRARCLGPSARGPG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

